Cargando…
Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study
BACKGROUND: Neoadjuvant intraperitoneal and systemic chemotherapy (NIPS) has shown promising results in gastric cancer (GC) with peritoneal metastasis. However, clinical practice experience of NIPS is still lacking in China. In this study, we investigate the efficacy and safety of NIPS in Chinese pa...
Autores principales: | Yang, Zhong-Yin, Yuan, Fei, Lu, Sheng, Xu, Wei, Wu, Jun-Wei, Xi, Wen-Qi, Shi, Min, Wang, Zhen-Qiang, Ni, Zhen-Tian, He, Chang-Yu, Yao, Xue-Xin, Zheng, Ya-Nan, Zhu, Zheng-Lun, Liu, Wen-Tao, Zhang, Jun, Zhang, Huan, Li, Chen, Yan, Chao, Yan, Min, Zhu, Zheng-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251062/ https://www.ncbi.nlm.nih.gov/pubmed/35795055 http://dx.doi.org/10.3389/fonc.2022.905922 |
Ejemplares similares
-
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
por: Shi, Min, et al.
Publicado: (2021) -
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
por: Yamamoto, Tomohisa, et al.
Publicado: (2022) -
Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: a Phase I Study
por: Kim, Dong-Wook, et al.
Publicado: (2021) -
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020) -
Hyperthermic Intraperitoneal Chemotherapy plus Intravenous Chemotherapy of Paclitaxel with or without Sintilimab in Gastric Cancer: A Comparative Study
por: Zhang, Zao, et al.
Publicado: (2022)